Pharmaceutical products

Tender description

NHS Framework Agreement for proprietary pharmaceuticals – London – Tranche A. Offer reference number: CM/PHR/15/5483. Period of Framework Agreement. CM/PHR/15/5483/01 — NHS Framework Agreement for proprietary pharmaceuticals — London — Tranche A — 1.9.2018 — 31.8.2020 with an option to extend (at the authority’s discretion) for up to 24 months. CM/PHR/15/5482/02 — NHS Framework Agreement for proprietary pharmaceuticals — London — Tranche A (Antiretrovirals) — 1.9.2018 — 31.8.2019 with an option to extend (at the Authority’s discretion) for up to 12 months. CM/PHR/15/5483/03 — North of England – Tranche A — Symtuza only — 1.9.2018 — 28.2.2019. South of England — Tranche A — Symtuza only — 1.9.2018 — 31.8.2019. NHS Framework Agreement for Proprietary pharmaceuticals — London — Tranche A — 1.9.2018 – 31.8.2020 with an option to extend (at the Authority’s discretion) for up to 24 months. Products associated with the lots are listed on Document No. 05 of the Invitation to offer. Each individual National Product Code (NPC) pack description in each of the regions (South of England) is deemed to be a separate product for the application of the award criteria. There is no restriction on the number of products that bidders can offer for, or be awarded. The Framework Agreement is intended for use by the Department of Health, Public Health England and the NHS in England. The framework may also be used by private sector contractors and agents working on behalf of the above. NHS Framework Agreement for Proprietary pharmaceuticals – London – Tranche A (Antiretrovirals) — 1.9.2018 – 31.8.2019 with an option to extend (at the Authority’s discretion) for up to 12 months. Products associated with the lots are listed on Document No 05 of the invitation to offer. Each individual National product code (NPC) pack description in each of the regions (South of England) is deemed to be a separate product for the application of the award criteria. There is no restriction on the number of products that bidders can offer for, or be awarded. The Framework Agreement is intended for use by the Department of Health, Public Health England and the NHS in England. The Framework may also be used by private sector contractors and agents working on behalf of the above. CM/PHR/15/5483/03 — North of England — Tranche A — Symtuza only — 1.9.2018 — 28.2.2019. South of England — Tranche A — Symtuza only — 1.9.2018 — 31.8.2019. Products associated with the lots are listed on Document No. 05 of the invitation to offer. Each individual National Product Code (NPC) pack description in each of the regions (South of England) is deemed to be a separate product for the application of the award criteria. There is no restriction on the number of products that bidders can offer for, or be awarded. The Framework Agreement is intended for use by the Department of Health, Public Health England and the NHS in England. The framework may also be used by private sector contractors and agents working on behalf of the above.